Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)
Go back to Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)| AbbVie (NYSE: ABBV) | Delayed: 259.36 +2.44 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.92 | 52 Week High | $68.12 | |||
| Open | $258.54 | 52 Week Low | $50.71 | |||
| Day High | $260.22 | P/E | 56.26 | |||
| Day Low | $256.77 | EPS | $4.61 | |||
| Volume | 4,195,205 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 129.31 -1.55 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.86 | 52 Week High | $108.63 | |||
| Open | $130.93 | 52 Week Low | $71.39 | |||
| Day High | $131.65 | P/E | 71.44 | |||
| Day Low | $129.04 | EPS | $1.81 | |||
| Volume | 5,529,733 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 131.07 +0.59 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.48 | 52 Week High | $65.46 | |||
| Open | $131.44 | 52 Week Low | $47.97 | |||
| Day High | $131.71 | P/E | 89.16 | |||
| Day Low | $130.24 | EPS | $1.47 | |||
| Volume | 6,154,306 | |||||
| REGULUS THERAP (NASDAQ: RGLS) | Delayed: 8.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.16 | 52 Week High | $10.60 | |||
| Open | $8.16 | 52 Week Low | $2.13 | |||
| Day High | $8.16 | P/E | 0.21 | |||
| Day Low | $8.16 | EPS | $38.45 | |||
| Volume | 14 | |||||

